PuSH - Publication Server of Helmholtz Zentrum München

82 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
41.
Brandmaier, S. et al.: Response to Comment on Xu et al. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 2015;38:1858-1867. Diabetes Care 38, e216-e217 (2015)
42.
Herder, C.* et al.: Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: Results from the KORA F4 study. Diabetes Care 38, 91-96 (2015)
43.
Insel, R.A.* et al.: Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38, 1964-1974 (2015)
44.
Kemppainen, K.M.* et al.: Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care 38, 329-332 (2015)
45.
Kullmann, S. et al.: Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults. Diabetes Care 38, 1044-1050 (2015)
46.
Shariful Islam, S.M.* et al.: Effects of mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: A prospective, parallel-group, randomized controlled trial. Diabetes Care 38, e112-e113 (2015)
47.
Steck, A.K.* et al.: Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care 38, 808-813 (2015)
48.
Xu, T. et al.: Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 38, 1858-1867 (2015)
49.
Beyerlein, A. et al.: Timing of gluten introduction and islet autoimmunity in young children: Updated results from the BABYDIET study. Diabetes Care 37, e194-e195 (2014)
50.
Krause, S. et al.: GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial. Diabetes Care 37, 1675-1680 (2014)
51.
Laxy, M. et al.: The association between patient-reported self-management behavior, intermediate clinical outcomes, and mortality in patients with type 2 diabetes: Results from the KORA-A study. Diabetes Care 37, 1604-1612 (2014)
52.
Raz, I.* et al.: Treatment of recent-onset type 1 diabetic patients with DiaPep277: Results of a double-blind, placebo-controlled, randomized phase 3 trial. Diabetes Care 37, 1392-1400 (2014)
53.
Smith, L.B.* et al.: Factors associated with maternal-reported actions to prevent type 1 diabetes in the first year of the TEDDY study. Diabetes Care 37, 325-331 (2014)
54.
Stefan, N. ; Peter, A. & Häring, H.-U.: Comment on Hedderson et al. Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care 2014;37:1296-1303. Diabetes Care 37, e278-279 (2014)
55.
Bongaerts, B.W.* et al.: Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: The KORA F4 study. Diabetes Care 36, 1141-1146 (2013)
56.
Herder, C.* et al.: Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study. Diabetes Care 36, 3663-3870 (2013)
57.
Icks, A.* et al.: Drug costs in prediabetes and undetected diabetes compared with diagnosed diabetes and normal glucose tolerance: Results from the population-based KORA survey in Germany. Diabetes Care 36, 53-54 (2013)
58.
Lehmann, R.* et al.: Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 36, 2331-2338 (2013)
59.
Marzi, C. et al.: Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study. Diabetes Care 36, 1321-1326 (2013)
60.
Bongaerts, B.W.C.* et al.: Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: The KORA F4 study. Diabetes Care 35, 1891-1893 (2012)